Timing of Radiotherapy in Uveal Melanoma: A SEER-Based Comparison of Preoperative, Postoperative, and Intraoperative Approaches
Preprint
Abstract
Purpose: To analyze the effect of radiotherapy timing relative to surgery on patients’ survival and mortality rates in uveal melanoma (UM). Design: Retrospective cohort study using registry data from the Surveillance, Epidemiology, and End Results (SEER) database. Subjects: A total of 1,198 patients with UM were extracted from the SEER database and divided into three groups: preoperative radiotherapy, intraoperative radiotherapy (IORT), and postoperative radiotherapy. Methods: UM cases were extracted from the SEER database. Survival curves were generated based on the Kaplan-Meier method. An extended Cox regression was used to estimate the cancer-specific and all-cause mortality. Main Outcome Measures: Overall survival (including median survival) and hazard reductions for cancer-specific and all-cause mortality. Results: Preoperative radiotherapy revealed the highest median survival (4.93 years), followed by postoperative radiotherapy (4.76 years), and IORT (4.02 years). The preoperative strategy reduced the hazard of all-cause mortality by 42%, 50%, and 60% at 5-, 7-, and 10-year follow-up, respectively, compared with IORT. Findings were consistent in the cancer-specific sensitivity analysis (45%, 53%, and 62% reductions at the same time points). However, postoperative radiotherapy did not significantly reduce the cancer-specific mortality in comparison to IORT. Conclusions: Preoperative radiotherapy was associated with higher median overall survival and lower all-cause and cancer-specific mortality than IORT over 10 years of follow-up. Postoperative radiotherapy showed intermediate outcomes that did not differ significantly from IORT. Prospective studies with more detailed data on the temporal relation of radiotherapy timing and surgery are needed to confirm these findings.Keywords
This publication has 45 references indexed in Scilit:
- Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanomaGraefe's Archive for Clinical and Experimental Ophthalmology, 2018
- Adjuvant Sunitinib in High-Risk Patients with Uveal MelanomaOphthalmology, 2018
- Driver Mutations in Uveal MelanomaJAMA Ophthalmology, 2016
- Local Recurrence Significantly Increases the Risk of Metastatic Uveal MelanomaOphthalmology, 2016
- Local Recurrence After Primary Proton Beam Therapy in Uveal Melanoma: Risk Factors, Retreatment Approaches, and OutcomeAmerican Journal of Ophthalmology, 2015
- Proton Beam Therapy of Parapapillary Choroidal MelanomaAmerican Journal of Ophthalmology, 2014
- Retrospective Evaluation of Patients With Uveal Melanoma Treated by Stereotactic Radiosurgery With and Without Tumor ResectionJAMA Ophthalmology, 2013
- Local Recurrence After Uveal Melanoma Proton Beam Therapy: Recurrence Types and Prognostic ConsequencesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal MelanomaArchives of Ophthalmology (1950), 2006
- The Cox Model2000